Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07813663 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants

Name: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants — clinical trial record (NCT07813663)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorJazz Pharmaceuticals

Started2026-09-22

View on ClinicalTrials.gov ↗

Jazz Pharmaceuticals

34 trials monitored

See 1 trial at risk

This study will characterize the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of JZP269 in healthy participants.

Trial Details

NCT Number	NCT07813663
Lead Sponsor	Jazz Pharmaceuticals Collaborators: Jazz Pharmaceuticals Ireland Limited
Conditions	Healthy Participants
Enrollment	188 participants
Start Date	2026-09-22
Primary Completion	2027-02-27 (estimated)
Study Completion	2027-02-27 (estimated)
Updated on ClinicalTrials.gov	2026-09-10